Paper · 2026 · Open access
"Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences"
Zenodo (CERN European Organization for Nuclear Research) · Published 18 April 2026 · DOI 10.5281/zenodo.19648504
In brief
“"Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences"” is a 2026 paper by 1Monali Bharat More and 3 co-authors, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 4
Abstract
Artificial Intelligence (AI) is transforming the pharmaceutical industry by improving the efficiency, accuracy, and speed of drug discovery and development. Traditional drug discovery is time-consuming, costly, and associated with high failure rates. AI technologies such as Machine Learning, Deep Learning, and Natural Language Processing enable rapid analysis of large biological and chemical datasets, identification of novel drug targets, and prediction of drug–target interactions. AI also supports lead optimization, toxicity prediction, drug repurposing, and clinical trial design, thereby reducing development time and cost. Furthermore, AI enhances precision n medicine by analyzing patient-specific data for personalized therapy. Despite these advantages, challenges such as data quality, regulatory acceptance, and model interpretability remain. This review highlights the applications, advantages, limitations, and future perspectives of AI in drug discovery and development, emphasizing its role in ushering a new era in pharmaceutical sciences.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
More, B., Sonkawade, B., Mote, M., & Mote, L. (2026). "Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences". Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19648504
MLA 9
More, 1Monali Bharat, et al. “"Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences".” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.19648504.
Chicago
More, 1Monali Bharat, 2Rohakshini Balkrishna Sonkawade, 3Tai Mhalappa Mote, and 4Sakshi Lalchand Mote. 2026. “"Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences".” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19648504.
Harvard
More, B. et al. (2026) ‘"Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences"’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.19648504.
IEEE
B. More, B. Sonkawade, M. Mote, and L. Mote, “"Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences",” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.19648504.
BibTeX
@article{more2026role,
title = {{"Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences"}},
author = {More, 1Monali Bharat and Sonkawade, 2Rohakshini Balkrishna and Mote, 3Tai Mhalappa and Mote, 4Sakshi Lalchand},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.19648504},
url = {https://doi.org/10.5281/zenodo.19648504}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence
- drug discovery
- drug development
- machine learning
- deep learning
- natural language processing
- drug target identification
- drug-target interaction prediction
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
More, B., Sonkawade, B., Mote, M., & Mote, L. (2026). "Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences". Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19648504
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).
Who wrote this paper?
1Monali Bharat More, 2Rohakshini Balkrishna Sonkawade, 3Tai Mhalappa Mote, 4Sakshi Lalchand Mote.
What is the DOI of this paper?
10.5281/zenodo.19648504. The permanent link is https://doi.org/10.5281/zenodo.19648504.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.